Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 2,614 shares at $2.69 ($7,032)
  2. 4 Open-market sale Chief Executive Officer sold 7,960 shares at $2.69 ($21,412)
  3. 4 Open-market sale Chief Operating Officer sold 4,193 shares at $2.69 ($11,279)
  4. 4 Open-market sale Executive VP, Research sold 2,614 shares at $2.69 ($7,032)
  5. 4 Exercise or conversion Executive VP, Research acquired 2,500 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Exercise or conversion Chief Financial Officer acquired 3,000 shares (option exercise)
  15. 4 Open-market buy Director bought 8,000 shares at $13.11 ($104,880)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3/A Insider 3/A
  19. 4 Exercise or conversion Executive VP, Research acquired 3,152 shares (option exercise)
  20. 4 Grant or award Chief Executive Officer acquired 885 shares (grant or award)

Page 8 of 11 · 211 filings